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doi:10.1016/j.jmigvisual identification and a histologic diagnosis of endometrial cancer and hyperplasia.
Design: Prospective study (Canadian Task Force classification: II-2).
Setting: Department of obstetrics and gynecology, University of Eastern Piedmont, Novara, Italy.
Patients: 209 consecutive patients with abnormal uterine bleeding.
Interventions: White-light hysteroscopy and NBI hysteroscopy followed by direct biopsy.
Measurements and Main Results: The sensitivity and specificity of conventional hysteroscopy in predicting a diagnosis of
cancer and hyperplasia were, respectively, 84.21% (95% confidence interval [CI], 79.27–89.15) and 99.47% (95% CI, 98.49–
100.0), and 64.86% (95% CI, 58.39–71.34) and 98.77% (95% CI, 97.27–100.0), and of NBI hysteroscopy were 94.74% (95%
CI, 91.71–97.76) and 97.89% (95% CI, 95.95–99.84), and 78.38% (95% CI, 72.8–83.96) and 97.67% (95% CI, 96.63–99.72).
The concordance of conventional and NBI hysteroscopy with the histopathologic findings (measured using the Cohen k) was,
respectively, 88.80% (95% CI, 86.2%–96.3%) and 91.78% (95% CI, 89.6%–98.2%), a difference of 2.98% (95% CI, 0–9) in
favor of NBI.
Conclusion: Narrow-band imaging hysteroscopy can accurately predict a histologic diagnosis of endometrial cancer or
hyperplasia. Journal of Minimally Invasive Gynecology (2010) 17, 620–625  2010 AAGL. All rights reserved.Keywords: Endometrial cancer; Endometrial hyperplasia; Hysteroscopy; Narrow-band imagingIn 1971, Folkman [1] first reported that tumor growth and
progression depend on angiogenesis, and since then, further
evidence has been collected that indicates that angiogenic
intensity may have a prognostic role in a number of malig-
nant lesions including endometrial cancer and its precursors.
In 1999, Abulafia et al [2] evaluated angiogenesis in uterine
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.2009.10.014specimens. Subsequently, in 2006, Stefansson et al [3]
observed that vessels associated with endometrial cancer
are structurally and functionally abnormal and that the struc-
tural changes are associated with more frequent vascular
invasion and decreased survival.
Hysteroscopy is useful for diagnosing symptomatic endo-
metrial diseases. However, Lasmar et al [4] have reported that
its sensitivity is no more than 80% for endometrial cancer,
and 56.3% for hyperplasia, which suggests that the subjective
interpretation of morphologic changes in the endometrial
mucosa is not sufficient to draw diagnostic conclusions.
Hysteroscopy with direct biopsy is currently considered the
criterion standard for diagnosis of endometrial diseases,
and has advantages over dilation and curettage, in particular
when diagnosing focal intracavity diseases [5].
Narrow-band imaging (NBI) is a new real-time imaging
technique based on modifying spectral features by narrowing
the bandwidth of spectral transmittance using optical filters.
This highlights the tissue microvasculature primarily as
Surico et al. Narrow Band Imaging Hysteroscopy 621a result of the differential optical absorption of light by hemo-
globin, in particular in the blue range. The NBI filter is placed
in the light path in front of a red-green-blue rotatory filter and
cuts all but the 2 wavelengths of 415 and 540 nm. The first
penetrates the surface mucosa and provides information
about its capillary pattern; the second penetrates the tissue
more deeply and enables visualization of the thicker submu-
cosal vessels. An image processor creates a composite color
image on a monitor, with the 415-nm beam being allocated to
the B and G channels, and the 514-nm beam to the R channel,
which is why the capillary vessels appear brown-black. In ad-
dition to magnification, NBI enables visualization of the mu-
cosal pattern and surface microvasculature by means of an
on-off switch located on the head of the endoscope [6–9].
A number of recently published studies have highlighted
the potential role of NBI in the early detection of head and
neck cancers [10], follow-up of patients with recurrent non-
muscle invasive bladder carcinoma [11], and identification
of dysplastic and malignant airway lesions in patients at
risk [12]. Most of the authors who have used the NBI magni-
fication system in gastrointestinal diseases have concluded
that it will soon become the endoscopy standard because of
its ability to enable identification of abnormal microvessels
that are difficult or impossible to visualize using conventional
methods [7,13].
Narrow-band imaging has been used by gynecologists to
detect peritoneal endometriosis implants during laparoscopy,
and some studies have demonstrated that it can be used to
identify and remove even small implants [14,15]. We first
suggested using the NBI system to detect endometrial
lesions in 2009 [9]; however, to our knowledge, there are still
no published studies describing the results. The objective
of the present study was to estimate the diagnostic accuracy
of NBI hysteroscopy in enabling visual identification of
endometrial cancer and hyperplasia.Materials and Methods
209 consecutive patients referred to the department of ob-
stetrics and gynecology at the University of Eastern Pied-
mont, Novara, Italy, underwent NBI hysteroscopy between
December 2007 and December 2008. Inclusion criteria
were abnormal uterine bleeding (AUB), no evidence of ab-
normalities on a Papanicolaou smear test, no use of anticoag-
ulant agents, and a transvaginal ultrasonographic endometrial
thickness greater than 4 mm in the case of menopausal pa-
tients [16]; and exclusion criteria were inability to provide
written informed consent, age younger than 18 years, ongo-
ing gonadotropin-releasing hormone agonist therapy, and
a history of endometrial cancer.
In all of the procedures, the same endoscope system
(Olympus EXERA II Video; Olympus Medical Systems
Corp., Tokyo, Japan) was used. Hysteroscopy was performed
using a 5-mm hysteroscope with a 1.5-mm operating channel
(Karl Storz GmbH & Co., Inc., Tuttlingen, Germany) accord-
ing to the vaginoscopic technique in 72 cases. The distentionmediumwasphysiologic saline solutiondelivered at aworking
pressure of 80 to 100 mm Hg.
Biopsies were performed using 5F grasping forceps in-
serted through the operating channel or a Novak curette,
and polypectomy was performed using scissors or a bipolar
electrode (Versapoint Electrosurgery System, Ethicon, Inc.,
Somerville, NJ). If ultrasonography revealed the presence
an intracavitary lesion larger than 2 cm or if the patient did
not want to feel pain, operative hysteroscopy was performed
as inpatient day surgery using general or spinal anesthesia.
The cervix was grasped with a tenaculum and dilated to He-
gar 9, and an 8.5-mm diameter outer sheath resectoscope
(Olympus Medical Systems Corp.) equipped with a 12 optic
was inserted. The uterine cavity was distended using saline
solution delivered at a pressure of 70 to 100 mm Hg from
5-L pressure bags. The procedures were performed using
a loop electrode, with the electrosurgical generator set at
170 W for vaporization, and 80 W for coagulation. Intrave-
nous injection of 2 g of piperacillin was always administered
intraoperatively as antibiotic prophylaxis, and the patients
were discharged 6 hours after the procedure.
In premenopausal patients, hysteroscopy was scheduled
during the follicular phase of the menstrual cycle, when there
is little or no AUB [17], although a histologic diagnosis of
hyperplasia is difficult in this phase because bleeding can
hamper recognition of lesions because the entire uterine cav-
ity appears brown-black.
The criteria used to evaluate the endometrium using
white-light imaging (WLI) hysteroscopy have been previ-
ously described [4,18]. It has been reported that diagnosis
of endometrial diseases is aided by considering both the
morphologic and vascular aspects of the lesions. The NBI
system provides a better view of the vascular pattern of
endometrial lesions and enables identification of the
smaller vessels that cannot be seen using WLI because the
vasculature appears brown-black against the normal white-
pink mucosa [4,5,18].
In our experience, the characteristics associated with a his-
tologic diagnosis of hyperplasia are hyperemic mucosal re-
gions with abundant thin or minimally swelled, sometimes
corkscrew-like, regularly separated, arborescent microves-
sels of homogeneous diameter, and invisible or very narrow
vessels running between papillary excrescences (Fig. 1A and
1B); those associated with cancer have a complex, chaotic
vascular architecture, with unevenly sized, elongated, and
coiling, tortuous, thin-walled, and thickly branched micro-
vessels irregularly located on the lesion surface (Fig. 2A
and B). Invisible or thin regular vessels, vascularization of
the pedicle alone, and vascular proliferation in the direction
of lesion growth are particular to benign diseases (Videos
1–5).
The surgeon initially observed the uterine cavity using
WLI hysteroscopy, and made a diagnostic impression that
was recorded on a spreadsheet (Excel; Microsoft, Redmond,
WA). Subsequently, after pressing the button on the tele-
scope, NBI was used to reevaluate the endometrial mucosa
Fig. 1. Images of conventional (A) and narrow-band imaging (B) hysteroscopy because of endometrial hyperplasia.
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regularity of capillary vessels on surface mucosa), and the
surgeon confirmed or changed the diagnostic hypothesis,
which was again recorded on the spreadsheet. Time for
observation of the uterine cavity was about 30 seconds in
both cases. The surgeon then obtained direct biopsy
specimens for pathologic analysis.
Patients with evidence of benign disease (polyps and
myomas) were immediately treated at surgical hysteroscopy.
All of the procedures were performed by the same specialist
(L.L.), who has more than 10 years of experience. The hys-
teroscopist was not aware of the ultrasound results, and the
pathologists who analyzed the biopsy specimens were
blinded to the endoscopic findings.
In 1 patient, the specimens were insufficient to make a di-
agnosis, and in 1 case, the surgeon did not give a diagnostic
impression because of heavy bleeding; thus, comparison of
the 2 hysteroscopic diagnostic hypotheses with the biopsy re-
sults (taken as the criterion standard) was based on 209 cases.Fig. 2. Images of conventional (A) and narrow-band imaging (B) hysteroscopy beAll study protocols and procedures were approved by the
Ethics Committee of Ospedale Maggiore della Carita`, No-
vara, Italy, and all study participants gave informed consent.
The sample size was calculated using prestudy power
analysis, which indicated that 202 patients were necessary to
obtain 80%power at a significance level of p5.05. Histologic
results were compared with the examiner’s diagnostic hypoth-
eses after conventional and NBI hysteroscopy. Categorical
variables are given as absolute numbers and percentages,
and continuous variables as mean (SD). Sensitivity and spec-
ificity were calculated with their 95% confidence intervals
(CIs) for the diagnoses of endometrial cancer and hyperplasia,
and the c2 test was used to analyze categorical variables.
Agreement between the criterion standard and the 2 endo-
scopic techniques was measured using the Cohen k test for
multiple choices, and the differences between the concor-
dances (the related 95% CIs) were calculated. Data were ana-
lyzed using Epi Info statistical software, version 3.5. A p value
of,.05 was considered statistically significant.cause of endometrial cancer.
Table 1
Patient Characteristics*
Characteristic EC1 EC2 Total p Value
Age, yr 69.57 58.22 59.25 ,.05
Body mass index 24.83 23.84 23.93 ..05
Menopause 19 140 159 ..05
Premenopause 0 50 50 ..05
HRT 0 11 11 ..05
Tamoxifen 0 4 4 ..05
No therapy 19 175 194 ..05
EC1 5 with endometrial cancer; EC2 5 without endometrial cancer;
HRT 5 hormone therapy.
* Data are given as the mean or as the number of patients.
Table 2




Hysteroscopy Cancer Hyperplasia Myoma Normal Polyp Total
Cancer 16 0 0 0 0 16
Hyperplasia 2 24 0 0 0 26
Myoma 0 0 4 0 0 4
Normal 1 9 0 87 0 97
Polyp 0 4 0 0 62 66
Total 19 37 4 87 62 209
c25 6 928 182; p5 .000; observed concordance, 92.34%; expected con-
cordance determined by (Column result! Row result)/Observed, 31,62%;
Cohen k, 88,80%.
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The enrolled patients had a mean (SD) age of 59 (111/2)
years, and included 159 postmenopausal women (76.1%;
95% CI, 69.7–81.7) and 50 premenopausal women (23.9%;
95% CI, 18.3–30.3). Eleven patients (5.3%; 95% CI, 2.7–
9.2) were receiving hormone therapy, 4 (1.9%; 95% CI,
0.5–4.8) reported taking tamoxifen, and 194 (92.8%; 95%
CI, 88.4–95.9) were not receiving any treatment. As ex-
pected, the group of patients with endometrial cancer were
older (mean, 69.6 vs 59.2 years) (Table 1).
No adverse events such as uterine perforation, pelvic
infection, or secondary hemorrhage occurred during the
procedures.
At histopathologic analysis, endometrial biopsy findings
indicated the presence of endometrial cancer in 19 patients
(9.1%; 95% CI, 5.6–13.8), including 2 with concomitant
atypical hyperplasia, and endometrial hyperplasia in 37
(17.7%; 95% CI, 12.8–23.6), 33 with simple and 4 with
complex hyperplasia without atypia; a myoma was found
in 4 patients (1.9%; 95% CI, 0.5–4.8), and a polyp in 62
(29.7%; 95% CI, 23.6–36.4). The remaining 87 biopsy
specimens (41.6%; 95% CI, 34.8–48.6) were normal.
Histological findings were first compared with the
surgeon’s diagnostic hypothesis based on conventional
WLI hysteroscopic visualization of the endometrial mucosa
(Table 2). The diagnosis was correct in 16 patients with en-
dometrial cancer and 24 with hyperplasia. The sensitivity
and specificity of WLI hysteroscopy in detecting endometrial
cancer were, respectively, 84.21% (95% CI, 79.27–89.15)
and 99.47% (95% CI, 98.49–100.0), and for hyperplasia
were 64.86% (95% CI, 58.39–71.34) and 98.77% (95% CI,
97.27–100.0).
Comparison of the histopathologic findings with the sur-
geon’s diagnostic hypothesis after NBI hysteroscopy
(Table 3) showed agreement in 29 patients with hyperplasia
and 18 with endometrial cancer. The sensitivity and specific-
ity of NBI hysteroscopy in detecting cancer were, respec-
tively, 94.74% (95% CI, 91.71–97.76) and 97.89% (95%
CI, 95.95–99.84), and for hyperplasia were 78.38% (95%
CI, 72.8–83.96) and 97.67% (95% CI, 96.63–99.72). The
positive and negative predictive values of NBI hysteroscopyin comparison with histologic analysis were, respectively,
94.12% (95% CI, 90.93–97.31) and 94.44% (95% CI,
91.33–97.55).
Use of the NBI system significantly increased sensitivity
(p ,.05) in diagnosing both endometrial cancer and hyper-
plasia; there was a slight decrease in specificity, but this
was not statistically significant (p ..05).
Insofar as diagnostic accuracy, the observed concordance
of conventional and NBI hysteroscopy with histopathologic
analysis was, respectively, 92.34% (Cohen k, 88.8%) and
94.26% (Cohen k, 91.78%), with a statistically significant
difference of 2.98% (95% CI, 0–9).Discussion
It has been reported that a diagnosis based on mucosal
pattern correlates with histologic findings [4,19]; however,
a number of studies have found that a subjective
hysteroscopic evaluation based on experience does not
always enable identification of endometrial cancer and
hyperplasia [4,20]. Angiogenesis is considered essential for
transition from premalignant to malignant endometrial
disease; thus, evaluation of irregularities in mucosal vessels
might be an ideal means of identifying hyperplasia and
early-stage cancer [2,3].
Narrow-band imaging is a new optical technology that
uses special narrow-band filters in the endoscopic system.
In particular, the blue filter is designed to correspond to the
peak absorption spectrum of hemoglobin to emphasize the
image of capillaries on the surface mucosa. The NBI system
has thus far been recognized as a potentially powerful means
of diagnosing gastrointestinal diseases, head and neck can-
cers, urothelial carcinoma of the bladder, and precancerous
airway lesions. However, to our knowledge, the present study
is the first designed to assess whether it can increase concor-
dance between hysteroscopy and histologic findings in the
diagnosis of endometrial diseases.
We used both conventional and NBI hysteroscopy to
examine the uterine cavity in 209 patients referred to our
department because of AUB. Histologic analysis revealed
Table 3




hysteroscoopy Cancer Hyperplasia Myoma Normal Polyp Total
Cancer 18 4 0 0 0 22
Hyperplasia 1 29 0 2 1 33
Myoma 0 0 4 0 0 4
Normal 0 3 0 85 0 88
Polyp 0 1 0 0 61 62
Total 19 37 4 87 62 209
NBI 5 narrow-band imaging.
c2 5 7 110 052; p 5 .000; observed concordance, 94,26%; expected
concordance determined by (Column result – Row result)/Observed,
30,12%; Cohen k, 91,78%.
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hyperplasia than that observed in the series by Lasmar et al
[17], a difference that may be explained in that 51.3% of their
patients were younger than 45 years, whereas 76.1% of our
patients were menopausal, and we routinely performed
transvaginal ultrasonography before study enrollment,
which, according to Gull et al [16], makes it possible to
exclude patients at no risk of malignant disease.
The conventional hysteroscopic classification was based
on previously reported criteria (4,18), whereas NBI enabled
clear identification of the vascular patterns associated with
hyperplasia (abundant, thin, homogeneous surface vessels)
and cancer (thick, diffuse, irregular vessels). We observed
that the sensitivity of NBI hysteroscopy in detecting endome-
trial cancer and hyperplasia was significantly greater than that
of WLI hysteroscopy, with no significant difference in
specificity, and NBI improved the accuracy of white-light
hysteroscopy in predicting histologic findings of endometrial
cancer and hyperplasia by a statistically significant 2.9%. As
expected, there was no improvement in the diagnoses of nor-
mal endometrium or benign diseases because NBI is more
useful in the case of diseases characterized by an abnormal
vascular pattern.
Using NBI led to an increase in the number of false-
positive findings; however, almost all of these were related
to the first 100 procedures, and if these are excluded, NBI
specificity was 98.36% (95%CI, 96.00–99.99) for cancer
and 98.88% (95%CI, 96.9–99.9) for hyperplasia. The reason
for this may be that the surgeon must become used to the
effect of NBI on capillary enhancement and memorize the
patterns correlated with each histologic finding. The sensitiv-
ity of conventional hysteroscopy in detecting cancer and
hyperplasia was slightly higher than that reported by Lasmar
et al [17], possibly because all of our procedures were
performed by the same skilled surgeon.
Despite the promising results, our study has some limita-
tions. First, it involved only a small number of patients and
was conducted at a single academic institution. Second, the
accuracy of NBI hysteroscopy in predicting histologic find-
ings was not tested by assessing interobserver variability;however, all of the procedures were performed by the same
skilled surgeon, who may have been influenced by the
white-light appearance of the lesions. Third, although it can
make it difficult to diagnose hyperplasia at histologic analysis,
we decided to perform the procedures during the proliferative
phase of the menstrual cycle, when there is little or no AUB,
because bleeding can hamper NBI visualization of lesions.
None of our patients had severe anemia or chronic endometri-
tis; however, we can speculate that these conditions may alter
the accuracy of NBI because of the reduced absorption of blue
light by hemoglobin or hypervascularization.
In our opinion, NBI could become a useful additional
method for early identification of endometrial diseases, in
particular, hyperplasia, which currently represents a challenge
for gynecologists because of the lack of highly sensitive mor-
phologic criteria. However, we were unable to identify any
NBI criteria for the differential diagnosis of simple, complex,
and atypical hyperplasia because of the limited number of
cases with complex and atypical hyperplasia in our series.
Another interesting question is whether the increased
diagnostic accuracy observed in the present study will be
confirmed by a series of procedures performed by residents.
Conclusion
Conventional WLI hysteroscopy is a well-established,
highly sensitive, and highly specific means of diagnosing in-
trauterine diseases. However, our results demonstrate that use
of the NBI system by an experienced surgeon can increase its
diagnostic accuracy. Large-scale, multicenter, randomized
trials are needed to confirm the potential of NBI for studying
the endometrium.Supplementary Data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.jmig.2009.10.
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